IL165522A0 - Controlled ovarian hyperstimulation - Google Patents

Controlled ovarian hyperstimulation

Info

Publication number
IL165522A0
IL165522A0 IL16552204A IL16552204A IL165522A0 IL 165522 A0 IL165522 A0 IL 165522A0 IL 16552204 A IL16552204 A IL 16552204A IL 16552204 A IL16552204 A IL 16552204A IL 165522 A0 IL165522 A0 IL 165522A0
Authority
IL
Israel
Prior art keywords
ovarian hyperstimulation
controlled ovarian
controlled
hyperstimulation
ovarian
Prior art date
Application number
IL16552204A
Other languages
English (en)
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of IL165522A0 publication Critical patent/IL165522A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16552204A 2002-06-07 2004-12-02 Controlled ovarian hyperstimulation IL165522A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077221 2002-06-07
PCT/NL2003/000370 WO2003103770A2 (en) 2002-06-07 2003-06-06 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Publications (1)

Publication Number Publication Date
IL165522A0 true IL165522A0 (en) 2006-01-15

Family

ID=29724462

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16552204A IL165522A0 (en) 2002-06-07 2004-12-02 Controlled ovarian hyperstimulation

Country Status (21)

Country Link
US (1) US7815912B2 (no)
EP (1) EP1511537B1 (no)
JP (1) JP2005530818A (no)
KR (1) KR20050058285A (no)
CN (1) CN1684737A (no)
AU (1) AU2003274929B2 (no)
BR (1) BR0305033A (no)
CA (1) CA2488719A1 (no)
EA (1) EA009371B1 (no)
ES (1) ES2399962T3 (no)
IL (1) IL165522A0 (no)
IS (1) IS7586A (no)
ME (1) MEP39308A (no)
MX (1) MXPA04012246A (no)
NO (1) NO20045304L (no)
NZ (1) NZ536984A (no)
PL (1) PL373991A1 (no)
RS (1) RS105004A (no)
UA (1) UA81251C2 (no)
WO (1) WO2003103770A2 (no)
ZA (1) ZA200409857B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2114412B1 (en) * 2007-01-08 2010-07-14 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
US9353172B2 (en) 2011-07-18 2016-05-31 Arts Biologics A/S Long acting biologically active luteinizing hormone (LH) compound
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
SG11201900461UA (en) 2016-07-21 2019-02-27 ObsEva SA Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
JP2022546716A (ja) 2019-09-03 2022-11-07 オブセヴァ エス．エー． 胚着床を促進し、流産を防止するためのオキシトシンアンタゴニスト投与レジメン
US20230102503A1 (en) 2020-02-10 2023-03-30 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
CN1199642A (zh) * 1997-05-16 1998-11-25 Asta药物股份公司 治疗不育症的lhrh－拮抗剂
US6653286B1 (en) 1997-06-20 2003-11-25 Akzo Nobel Nv Gonadotropin releasing hormone antagonist
HU228736B1 (en) * 1998-04-23 2013-05-28 Zentaris Ivf Gmbh Use of lhrh atnagonists in the production of pharmaceutical compostion for the treatment of fertility disorders
JP2002537349A (ja) * 1999-02-24 2002-11-05 ノボ ノルディスク アクティーゼルスカブ 不妊症の治療
US20030092628A1 (en) * 1999-06-23 2003-05-15 De Greef Henrik Johan Matthieu Maria Gonadotropin releasing hormone antagonist
AU6263800A (en) 1999-06-23 2001-01-31 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
DK1434600T3 (da) * 2001-09-12 2009-05-25 Serono Lab Anvendelse af LH i kontrolleret ovarie-hyperstimulation
DE60223284T2 (de) 2001-12-21 2008-07-31 Pantarhei Bioscience B.V. Verfahren zur regulierten hyperstimulation der eierstöcke und pharmazeutischen kit zur verwendung in diesem verfahren

Also Published As

Publication number Publication date
IS7586A (is) 2004-12-03
NO20045304L (no) 2005-02-07
MEP39308A (en) 2011-02-10
EP1511537A2 (en) 2005-03-09
AU2003274929A1 (en) 2003-12-22
CN1684737A (zh) 2005-10-19
EA200401619A1 (ru) 2005-06-30
ES2399962T3 (es) 2013-04-04
PL373991A1 (en) 2005-09-19
RS105004A (en) 2007-02-05
UA81251C2 (en) 2007-12-25
US7815912B2 (en) 2010-10-19
AU2003274929B2 (en) 2008-04-10
ZA200409857B (en) 2006-02-22
CA2488719A1 (en) 2003-12-18
US20050235374A1 (en) 2005-10-20
WO2003103770A2 (en) 2003-12-18
KR20050058285A (ko) 2005-06-16
EA009371B1 (ru) 2007-12-28
EP1511537B1 (en) 2012-11-21
NZ536984A (en) 2008-01-31
BR0305033A (pt) 2004-11-09
WO2003103770A3 (en) 2004-04-22
MXPA04012246A (es) 2005-04-08
JP2005530818A (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
GB2385111B (en) Control apparatus
EP1547230A4 (en) CONTROL MOVEMENT SYSTEM
AU2003232122A8 (en) Ctp-extended erythropoietin
GB0201228D0 (en) Access control
IL163652A0 (en) Substituted hydroxyethylamines
GB0211257D0 (en) Novel heterocycles
DE60314378D1 (en) Kristalline polymorphe form von irinotecan-hyrochlorid
IL166740A0 (en) Substituted heterocyclylpyrimidines
GB0221167D0 (en) Control apparatus
IL165522A0 (en) Controlled ovarian hyperstimulation
SI1487778T1 (sl) Substituirani 4-aminocikloheksanoli
GB0208877D0 (en) Behicle control
GB0209989D0 (en) Novel heterocycles
GB2395074B (en) Control circuit
AU150572S (en) Control unit
GB0204681D0 (en) Ink-key control
GB0511237D0 (en) Control unit
PL377325A1 (pl) Podstawione benzodioksepiny
GB2395073B (en) Control circuit
GB0209988D0 (en) Novel Heterocycles
GB0301989D0 (en) Control belt
GB0301420D0 (en) Control belt
CA94853S (en) Lighting control
CA94852S (en) Lighting control
CA94851S (en) Lighting control